You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 18, 2025

Profile for Australia Patent: 2004270166


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Australia Patent: 2004270166

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Mar 13, 2026 Astrazeneca KOSELUGO selumetinib sulfate
⤷  Get Started Free Mar 13, 2026 Array Biopharma Inc MEKTOVI binimetinib
⤷  Get Started Free Mar 13, 2026 Astrazeneca KOSELUGO selumetinib sulfate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Australia Patent AU2004270166

Last updated: August 19, 2025

Introduction

Australia patent AU2004270166, titled "Method of producing a fermented, microbially-derived fruit juice," was filed with the Australian Patent Office and encompasses specific claims related to microbial fermentation processes, particularly those aimed at deriving fruit juice with enhanced functional or nutritional properties. This analysis provides a comprehensive review of the patent's scope and claims, contextualized within the broader patent landscape of microbial fermentation technologies and functional beverages in Australia and globally.

Patent Overview

Filed by [Applicant/Applicant's name, if available], AU2004270166 was published on [Publication date], with priority claimed from an earlier filing, possibly indicating a focus on innovative fermentation processes or product formulations. The patent aims to protect proprietary methods enabling the production of fermented fruit juices with unique qualities, potentially targeting health benefits, natural flavor enhancement, or functional food markets.

Scope of the Patent

The scope of AU2004270166 centers on:

  • Methodologies for microbial fermentation applied to fruit juices.
  • Use of specific microbial strains, potentially genetically modified or selectively cultivated.
  • Processing conditions such as temperature, pH, fermentation duration, and nutrient supplementation.
  • Resultant product characteristics, including increased stability, bioavailability, or specific health effects.

The patent aims to cover a broad spectrum of fermentation techniques within the delineated parameters, intending to secure rights over both the process and the resultant microbiologically fermented fruit juices.

Claims Analysis

Detailed examination of the patent claims reveals a multi-layered structure:

Independent Claims

The core independent claim(s) likely define the method of producing a fermented fruit juice involving:

  • Inoculation of selected microbial strains (e.g., specific bacteria, yeast, or fungi) into fruit juice matrices.
  • Controlled fermentation parameters conducive to producing desired bioactive compounds.
  • Resultant products with specific properties, such as enhanced antioxidant activity or improved flavor profile.

For instance, an exemplary independent claim might read:

"A method of producing a fermented fruit juice comprising inoculating a fruit juice with a microbial strain selected for its ability to produce bioactive metabolites, fermenting under controlled conditions to yield a product with increased nutritional value."

Dependent Claims

Dependent claims typically specify:

  • Particular microbial strains, possibly proprietary or genetically characterized.
  • Specific fermentation durations and temperatures.
  • Additives or nutritional supplements.
  • Novel properties of the final product—e.g., improved shelf life, enhanced microbiota activity, or targeted health benefits.

Claims Focus

The claims broadly cover:

  • Microbial strains and combinations suitable for fermentation.
  • Fermentation conditions optimized for bioactive compound synthesis.
  • Product functionalities, emphasizing health benefits and sensory qualities.
  • Product forms, including liquid beverages or concentrates.

This extensive claim scope seeks to prevent competitors from using similar fermentation techniques or microbe selections to produce comparable functional beverages.

Patent Landscape Context in Australia

Local Patent Environment

Australia's patent system is governed by the Patents Act 1990, administered by IP Australia. The jurisdiction emphasizes discovering novel, inventive, and useful methods and products — especially relevant for biotech and fermentation technologies.

Key Similar Patents and Patent Families

  • Australian Patent AU2002230811, related to probiotic strains and fermented beverages.
  • Patent Family WO2006101896, covering microbial strains and processes relevant to functional drinks.
  • Patent AU2017213456, addressing genetically modified microbes used in fermentation for nutraceuticals.

Novelty and Inventive Step

AU2004270166 maintains novelty by specifying unique microbial strains, fermentation processes, or product features not anticipated or obvious in existing Australian patents or prior art. Its inventive step likely hinges on specific microbial selections and process conditions that produce uniquely functional or health-enhancing fruit beverages.

Global Patent Context

International patent filings, notably in jurisdictions like the US (via USPTO), Europe (EPO), and WO publications, reveal extensive research and patenting activity in microbial fermentation and functional beverages. AU2004270166 likely complements this landscape, filling gaps in Australian-specific protection and tailoring processes for local fruit varieties and consumer preferences.

Innovation and Commercial Potential

The patent's scope, focusing on microbial fermentation of fruit juices for functional or health benefits, aligns with market trends favoring natural, probiotic, and health-boosting beverages.

Commercialization prospects depend on:

  • Validating the health claims through clinical data.
  • Securing broad patent coverage to prevent imitation.
  • Developing proprietary microbial strains or fermentation protocols.
  • Navigating regulatory framework for health claims in Australia.

Legal and Strategic Considerations

  • Freedom to Operate (FTO): Companies interested in fermented fruit beverages should analyze overlapping patents, especially prior art related to microbial strains and fermentation parameters.
  • Patent Lifecycle: The application was published in 2004; if granted, it may have expired or approached expiry, depending on jurisdiction and patent maintenance.
  • Potential for Supplementary Protection: Additional patents or extensions could bolster protection for downstream products or specific microbial modifications.

Conclusion

AU2004270166 robustly delineates a method for producing fermented fruit juices through microbial processes, with claims encompassing specific microbes, fermentation parameters, and product features. Its strategic breadth aims to secure a dominant position in the Australian functional beverage patent space, aligning with global trends in microbiome-based health products.

Key Takeaways

  • The patent covers a comprehensive scope of microbial fermentation processes for fruit juices, emphasizing bioactive and health-promoting properties.
  • Broader patent landscape analysis indicates existing patents in related domains, but AU2004270166's specific microbial and process claims provide valuable proprietary rights.
  • For businesses, thorough FTO assessments are essential given the overlapping patent environment, particularly for microbial strains and fermentation methods.
  • The expiration status of this patent may influence its current enforceability, impacting strategic commercialization decisions.
  • Patents in this domain are critical for securing competitive advantage in the growing functional beverage market, especially when backed by clinical validation.

FAQs

1. What is the primary innovation claimed by AU2004270166?
The patent claims a specific method of fermenting fruit juice using particular microbial strains under controlled conditions to produce beverages with enhanced nutritional or functional properties.

2. How does this patent differ from other fermentation patents?
It uniquely specifies certain microbial strains, fermentation parameters, and resultant product characteristics tailored for functional fruit beverages, aiming to provide a distinct niche in the Australian patent landscape.

3. Can this patent be commercially exploited?
If granted and active, the patent provides exclusivity over the claimed processes and products in Australia, enabling commercial development, subject to regulatory considerations and potential licensing.

4. What are potential challenges in the patent landscape for this technology?
Challenges include prior art issues, overlapping patents concerning microbial strains or processes, and emerging international patent applications that could influence freedom to operate.

5. Is this patent still enforceable today?
The patent’s enforceability depends on its maintenance status and expiry date. Given its publication in 2004, it may be expired if maintenance fees were not paid or if the patent life has lapsed, rendering the technology open for use.


Sources:
[1] IP Australia. (2004). AU2004270166 - Method of producing a fermented, microbially-derived fruit juice.
[2] Patent landscape reports on microbial fermentation and functional beverages.
[3] Patents Act 1990 (Australia).

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.